Unknown

Dataset Information

0

Regulation of B cell functions by S-nitrosoglutathione in the EAE model.


ABSTRACT: B cells play both protective and pathogenic roles in T cell-mediated autoimmune diseases by releasing regulatory vs. pathogenic cytokines. B cell-depleting therapy has been attempted in various autoimmune diseases but its efficacy varies and can even worsen symptoms due to depletion of B cells releasing regulatory cytokines along with B cells releasing pathogenic cytokines. Here, we report that S-nitrosoglutathione (GSNO) and GSNO-reductase (GSNOR) inhibitor N6022 drive upregulation of regulatory cytokine (IL-10) and downregulation of pathogenic effector cytokine (IL-6) in B cells and protected against the neuroinflammatory disease of experimental autoimmune encephalomyelitis (EAE). In human and mouse B cells, the GSNO/N6022-mediated regulation of IL-10 vs. IL-6 was not limited to regulatory B cells but also to a broad range of B cell subsets and antibody-secreting cells. Adoptive transfer of B cells from N6022 treated EAE mice or EAE mice deficient in the GSNOR gene also regulated T cell balance (Treg > Th17) and reduced clinical disease in the recipient EAE mice. The data presented here provide evidence of the role of GSNO in shifting B cell immune balance (IL-10 > IL-6) and the preclinical relevance of N6022, a first-in-class drug targeting GSNOR with proven human safety, as therapeutics for autoimmune disorders including multiple sclerosis.

SUBMITTER: Kim J 

PROVIDER: S-EPMC8246645 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2710918 | biostudies-literature
| S-EPMC6760305 | biostudies-literature
| S-EPMC4857760 | biostudies-literature
| S-EPMC9672173 | biostudies-literature
| S-EPMC4991380 | biostudies-literature
| S-EPMC5865173 | biostudies-literature
| S-EPMC5831954 | biostudies-literature
| S-EPMC6975265 | biostudies-literature
| S-EPMC1978180 | biostudies-literature
| S-EPMC3517124 | biostudies-literature